Difference between revisions of "Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[unchecked revision][checked revision]
 
(379 intermediate revisions by 13 users not shown)
Line 1: Line 1:
 +
Welcome!   
 +
 +
 +
We are creating content for all diseases with genetic findings in the current WHO Classification of Tumours books.  Please join the effort!   
 +
 +
 +
To volunteer: 
 +
 +
#Select a link in the table to your book(s) of interest to view specific authorship opportunities.  Additional books are in the process of being added.
 +
#'''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]''' with your disease page of interest.  You will be connected with an Associate Editor to help guide you through the process.
 +
#Complete the brief '''[https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>]''' to receive your log-in credentials.  Information on [[Description of CCGA Roles|<u>Authorship and Other Roles</u>]] with the CCGA is available.
 +
  
 
{| class="wikitable"
 
{| class="wikitable"
 +
|+BOOKS WITH CONTENT IN PROGRESS
 +
!Book Name
 +
!Book Edition
 +
!Book Acronym
 
|-
 
|-
−
|'''Disease'''||'''Page Type'''||'''Author'''||'''Associate Editor'''
+
|[[HAEM5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues]]
−
!Author Content (Pending or Complete)
+
|5th
−
!Editor Reviewed (Date)
+
|HAEM5
−
!Notes
 
 
|-
 
|-
−
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''|| ||Fabiola Quintero-Rivera (FQR)
+
|[[CNS5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of the Central Nervous System]]
−
|
+
|5th
−
|
+
|CNS5
−
|
 
 
|-
 
|-
−
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
+
|[[GTS5:Volunteer Assignments and Opportunities|WHO Classification of Genetic Tumour Syndromes]]
−
| ||FQR
+
|5th
−
|
+
|GTS5
−
|
 
−
|
 
 
|-
 
|-
−
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
+
|[[BRST5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of the Breast]]
−
| ||FQR
+
|5th
−
|
+
|BRST5
−
|
 
−
|
 
 
|-
 
|-
−
|    Polycythaemia Vera  (PV)||Disease
+
|[[STBT5:Volunteer Assignments and Opportunities|WHO Classification of Soft Tissue and Bone Tumours]]
−
| ||FQR
+
|5th
−
|
+
|STBT5
−
|
+
|}
−
|
+
 
−
|-
+
 
−
|    Primary Myelofibrosis  (PMF)||Disease
+
{| class="wikitable"
−
| ||FQR
+
|+BOOKS COMING SOON
−
|
+
!Book Name
−
|
+
!Book Edition
−
|
+
!Book Acronym
−
|-
 
−
|    Essential  Thrombocythaemia (ET)||Disease
 
−
| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
 
−
| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
 
−
| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Mastocytosis'''''||'''''Overview'''''|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Cutaneous  Mastocytosis||Disease
 
−
| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Systemic Mastocytosis||Disease
 
−
| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Mast Cell Sarcoma||Disease
 
−
| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Refractory Cytopenia  of Childhood||Disease|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Path Resident
 
−
|Jennelle Hodge (JH)
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Path Resident||JH
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang||JH
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori||JH
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang||JH
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+Path Resident||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+Path Resident
 
−
|JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca||JH
 
−
|Complete
 
−
|
 
−
|Need permission for figure?  Update WHO?
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng  Choy via Greg Conboy (Monash Health)||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy via Greg Conboy (Monash Health)||JH
 
−
|Complete
 
−
|
 
−
|Add WHO reference
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc, via Greg  Conboy (Monash Health)||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Path Resident  (Iris Martin)||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + resident||JH
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar  Iqbal||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|   Acute Myeloid Leukemia (AML) without  Maturation||Disease||Jennelle Hodge||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  Maturation||Disease||Jennelle Hodge||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and  Jialing Huang||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp||JH
 
−
|Complete
 
−
|
 
−
|Need permission for figure?
 
−
|-
 
−
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Path Resident||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + resident||JH
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + resident||JH
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera||JH
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease|| ||JH
 
−
|??
 
−
|
 
−
|
 
−
|-
 
−
|    ??Acute Leukaemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease|| ||JH
 
−
|??
 
−
|
 
−
|
 
−
|-
 
−
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
 
−
|Disease
 
−
|Kay Weng  Choy via Greg Conboy (Monash Health)
 
−
|JH
 
−
|Complete
 
−
|
 
−
|NON-WHO ENTITY
 
−
|-
 
−
|Acute Myeloid Leukemia (AML)  with NUP214-ABL1
 
−
|Disease
 
−
|Daynna Wolff+Path Resident
 
−
|JH
 
−
|PENDING
 
−
|
 
−
|NON-WHO ENTITY
 
−
|-
 
−
|Acute Myeloid Leukemia (AML)  with t(4;12)(q12;p13); CHIC2-ETV6
 
−
|Disease
 
−
|Daynna Wolff+Path Resident
 
−
|JH
 
−
|PENDING
 
−
|
 
−
|NON-WHO ENTITY
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''|| ||Yassmine Akkari (YA)
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|NK-Lymphoblastic Leukemia/Lymphoma||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|       Monoclonal B-cell  Lymphocytosis||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|B-cell Prolymphocytic Leukemia||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
 
−
|Jennelle Hodge
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Hairy Cell Leukemia||Disease||Snehal Patel
 
−
|Jennelle Hodge
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
 
−
|Jennelle Hodge
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
 
−
|Jennelle Hodge
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
 
−
|Jennelle Hodge
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Lymphoplasmacytic Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|   Waldenstrom  Macroglobulinemia||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Heavy Chain Diseases'''''||'''''Overview'''''|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Mu Heavy Chain  Disease||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|   Gamma Heavy Chain  Disease||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Alpha Heavy Chain  Disease||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Plasma Cell Neoplasms||'''''Overview'''''|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Plasma Cell Myeloma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Plasma Cell Myeloma  Variants||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Plasmacytoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|           Primary  Amyloidosis||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|           Light Chain  and Heavy Chain Deposition Disease||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|         POEMS Syndrome||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|         TEMPI Syndrome||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Nodal Marginal Zone Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Follicular Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Testicular Follicular  Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    In Situ Follicular  Neoplasia||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Duodenal-Type  Follicular Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Paediatric-Type Follicular Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Primary Cutaneous Follicle Centre Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Mantle Cell Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    In Situ Mantle Cell  Neoplasia||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease|| ||Greg Corboy (GC)
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|EBV-Positive Mucocutaneous Ulcer||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Lymphomatoid Granulomatosis||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Intravascular Large B-cell Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|ALK-Positive Large B-cell Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Plasmablastic Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Primary Effusion Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|   Multicentric Castleman  Disease||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Burkitt Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Burkitt-Like Lymphoma with 11q Aberration||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|T-cell Prolymphocytic Leukemia||Disease|| ||Snehal Patel
 
−
|Michelle Don
 
−
|
 
−
|
 
−
|-
 
−
|T-cell Large Granular Lymphocytic Leukemia||Disease|| ||Snehal Patel
 
−
|Michelle Don
 
−
|
 
−
|
 
−
|-
 
−
|Chronic Lymphoproliferative Disorder of NK Cells||Disease|| ||Snehal Patel
 
−
|Michelle Don
 
−
|
 
−
|
 
−
|-
 
−
|Aggressive NK-cell Leukemia||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Severe Mosquito Bite  Allergy||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Adult T-cell Leukemia/Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|     Enteropathy-Associated T-cell Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Hepatosplenic T-cell Lymphoma||Disease|| ||Snehal Patel
 
−
|Michelle Don
 
−
|
 
−
|
 
−
|-
 
−
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Mycosis Fungoides||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Sézary Syndrome||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Lymphomatoid  Papulosis||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|     Angioimmunoblastic  T-cell Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Follicular T-cell  Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease|| ||Snehal Patel
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''|| ||Associate Editor??
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Lymphomas Associated with HIV Infection||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|          Monomorphic  B-cell PTLD||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|          Monomorphic  T/NK-cell PTLD||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Histiocytic Sarcoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|   Langerhans Cell  Histiocytosis||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|   Langerhans Cell  Sarcoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Indeterminate Dendritic Cell Tumour||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Interdigitating Dendritic Cell Sarcoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Follicular Dendritic Cell Sarcoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Fibroblastic Reticular Cell Tumor||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Disseminated Juvenile Xanthogranuloma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Erdheim-Chester Disease||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
 
|-
 
|-
−
| || || ||
+
|[[DIG5:Volunteer Assignments and Opportunities|WHO Classification of Digestive System Tumours]]
−
|
+
|5th
−
|
+
|DIG5
−
|
 
 
|-
 
|-
−
| || || ||
+
|[[EYE5:Volunteer Assignments and Opportunities|WHO Classification of Eye and Orbit Tumours]]
−
|
+
|5th
−
|
+
|EYE5
−
|
 
 
|-
 
|-
−
| || || ||
+
|[[SKIN5:Volunteer Assignments and Opportunities|WHO Classification of Skin Tumours]]
−
|
+
|5th
−
|
+
|SKIN5
−
|
 
 
|-
 
|-
−
| || || ||
+
|[[HAN5:Volunteer Assignments and Opportunities|WHO Classification of Head and Neck Tumours]]
−
|
+
|5th
−
|
+
|HAN5
−
|
 
 
|-
 
|-
−
| || || ||
+
|[[ENDO5:Volunteer Assignments and Opportunities|WHO Classification of Endocrine and Neuroendocrine Tumours]]
−
|
+
|5th
−
|
+
|ENDO5
−
|
 
 
|-
 
|-
−
| || || ||
+
|[[MALE5:Volunteer Assignments and Opportunities|WHO Classification of Urinary and Male Genital Tumours]]
−
|
+
|5th
−
|
+
|MALE5
−
|
 
 
|-
 
|-
−
| || || ||
+
|[[PEDS5:Volunteer Assignments and Opportunities|WHO Classification of Paediatric Tumours]]
−
|
+
|5th
−
|
+
|PEDS5
−
|
 
 
|-
 
|-
−
| || || ||
+
|[[THOR5:Volunteer Assignments and Opportunities|WHO Classification of Thoracic Tumours]]
−
|
+
|5th
−
|
+
|THOR5
−
|
 
 
|-
 
|-
−
| || || ||
+
|[[FEMA5:Volunteer Assignments and Opportunities|WHO Classification of Female Genital Tumours]]
−
|
+
|5th
−
|
+
|FEMA5
−
|
 
 
|}
 
|}

Latest revision as of 12:29, 27 June 2024

Welcome!


We are creating content for all diseases with genetic findings in the current WHO Classification of Tumours books. Please join the effort!


To volunteer:

  1. Select a link in the table to your book(s) of interest to view specific authorship opportunities. Additional books are in the process of being added.
  2. Contact us with your disease page of interest. You will be connected with an Associate Editor to help guide you through the process.
  3. Complete the brief Volunteer Form to receive your log-in credentials. Information on Authorship and Other Roles with the CCGA is available.


BOOKS WITH CONTENT IN PROGRESS
Book Name Book Edition Book Acronym
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 5th HAEM5
WHO Classification of Tumours of the Central Nervous System 5th CNS5
WHO Classification of Genetic Tumour Syndromes 5th GTS5
WHO Classification of Tumours of the Breast 5th BRST5
WHO Classification of Soft Tissue and Bone Tumours 5th STBT5


BOOKS COMING SOON
Book Name Book Edition Book Acronym
WHO Classification of Digestive System Tumours 5th DIG5
WHO Classification of Eye and Orbit Tumours 5th EYE5
WHO Classification of Skin Tumours 5th SKIN5
WHO Classification of Head and Neck Tumours 5th HAN5
WHO Classification of Endocrine and Neuroendocrine Tumours 5th ENDO5
WHO Classification of Urinary and Male Genital Tumours 5th MALE5
WHO Classification of Paediatric Tumours 5th PEDS5
WHO Classification of Thoracic Tumours 5th THOR5
WHO Classification of Female Genital Tumours 5th FEMA5
Retrieved from "https://ccga.io/index.php?title=Volunteer_Assignments_and_Opportunities&oldid=14522"